Related Experiment Video
Updated: May 10, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
D Chakravarti1, V Ogryzko, H Y Kao
1Gene Expression Laboratory, The Salk Institute for Biological Sciences, La Jolla, California 92037, USA.
Abstract:
Nucleosomal histone modification is believed to be a critical step in the activation of RNA polymerase II-dependent transcription. p300/CBP and PCAF histone acetyltransferases (HATs) are coactivators for several transcription factors, including nuclear hormone receptors, p53, and Stat1alpha, and participate in transcription by forming an activation complex and by promoting histone acetylation. The adenoviral E1A oncoprotein represses transcriptional signaling by binding to p300/CBP and displacing PCAF and p/CIP proteins from the complex. Here, we show that E1A directly represses the HAT activity of both p300/CBP and PCAF in vitro and p300-dependent transcription in vivo. Additionally, E1A inhibits nucleosomal histone modifications by the PCAF complex and blocks p53 acetylation. These results demonstrate the modulation of HAT activity as a novel mechanism of transcriptional regulation.
Insights
Adenoviral E1A oncoprotein inhibits histone acetyltransferases (HATs) p300/CBP and PCAF, key regulators of gene transcription. This repression of HAT activity by E1A offers a new understanding of transcriptional regulation.
Area of Science:
- Molecular Biology
- Epigenetics
- Virology
Background:
- Nucleosomal histone modification is crucial for RNA polymerase II-dependent transcription.
- Histone acetyltransferases (HATs) like p300/CBP and PCAF act as coactivators for transcription factors, promoting histone acetylation and forming activation complexes.
- Adenoviral E1A oncoprotein is known to repress transcriptional signaling by interacting with p300/CBP and displacing other proteins.
Purpose of the Study:
- To investigate the direct effect of adenoviral E1A oncoprotein on the activity of p300/CBP and PCAF histone acetyltransferases.
- To determine if E1A modulates histone acetylation and transcription in vivo.
- To elucidate the mechanism by which E1A represses transcription.
Main Methods:
- In vitro assays to measure the HAT activity of p300/CBP and PCAF in the presence of E1A.
- In vivo studies to assess p300-dependent transcription.
- Analysis of nucleosomal histone modifications and p53 acetylation.
Main Results:
- E1A directly represses the histone acetyltransferase (HAT) activity of both p300/CBP and PCAF in vitro.
- E1A inhibits p300-dependent transcription in vivo.
- E1A blocks nucleosomal histone modifications mediated by the PCAF complex and inhibits p53 acetylation.
Conclusions:
- Adenoviral E1A oncoprotein directly inhibits the enzymatic activity of key histone acetyltransferases (HATs).
- E1A-mediated repression of HAT activity represents a novel mechanism for regulating transcription.
- These findings provide insights into viral oncoprotein function and epigenetic regulation of gene expression.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity
Anaphase Promoting Complex
Inhibition of CDK Activity
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Inhibitors of Viral Protein Synthesis

